文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

PPS豁免癌症中心附属医院、其他NCI指定癌症中心附属医院与其他提供癌症诊疗医院的比较

Comparison of Hospitals Affiliated With PPS-Exempt Cancer Centers, Other Hospitals Affiliated With NCI-Designated Cancer Centers, and Other Hospitals That Provide Cancer Care.
PubMed 文献 · JAMA Intern Med · 2019-01-01
一句话结论与美国国家癌症研究所癌症中心附属医院相比,PPS豁免癌症中心附属医院的医院特征、患者合并症负担及癌症手术结局总体相似,但患者术后脓毒症、急性肾衰竭和尿路感染发生率更低。

该回顾性队列研究利用美国医院协会年度调查和《美国新闻与世界报道》最佳医院排名数据,比较了15家PPS豁免癌症中心附属医院、54家NCI癌症中心附属医院和3578家其他提供癌症诊疗的医院。研究纳入2011年1月1日至2015年5月31日接受9种癌症手术之一的全部Medicare受益人,采用分层逻辑回归比较18项术后结局。结果显示PPS豁免癌症中心与NCI癌症中心附属医院在15/18项调整后结局上相似;与PPS豁免癌症中心相比,NCI癌症中心患者术后脓毒症(3.1% vs 1.7%;P=.002)、急性肾衰竭(6.2% vs 3.9%;P=.01)和尿路感染(6.4% vs 4.0%;P=.002)发生率更高。与其他提供癌症诊疗的医院相比,PPS豁免癌症中心状态与7/18项结局改善相关,包括死亡率、脓毒症、急性肾衰竭、呼吸衰竭和抢救失败。

要点

  • PPS豁免癌症中心(n=15)与NCI癌症中心(n=54)附属医院在医院特征、基本癌症相关服务和患者合并症负担上相似。
  • PPS豁免癌症中心的《美国新闻》声誉评分显著高于NCI癌症中心(均值[SD] 17.5[24.0] vs 2.6[4.8];P<.001),但肿瘤患者量、患者安全评级、合并症负担、护士配置、US News总癌症评分或生存评分无差异。
  • PPS豁免癌症中心与NCI癌症中心附属医院在18项调整后术后结局中的15项相似,包括死亡率、再入院和手术部位感染。
  • 与PPS豁免癌症中心相比,NCI癌症中心患者术后脓毒症(3.1% vs 1.7%;P=.002)、急性肾衰竭(6.2% vs 3.9%;P=.01)和尿路感染(6.4% vs 4.0%;P=.002)发生率更高。
  • 与其他提供癌症诊疗的医院(n=3578)相比,PPS豁免癌症中心状态与18项结局中的7项改善相关,包括死亡率、脓毒症、急性肾衰竭、呼吸衰竭和抢救失败。

适用人群与场景

  • 2011年1月1日至2015年5月31日接受9种癌症手术之一(脑肿瘤切除、结直肠切除、膀胱切除、食管切除、胃切除、肝切除、肺切除、胰腺切除、前列腺切除)的全部Medicare受益人。

研究设计与关键结果

  • 研究类型为回顾性队列研究,使用美国医院协会年度调查和《美国新闻》最佳医院排名数据,纳入15家PPS豁免癌症中心附属医院、54家NCI癌症中心附属医院和3578家其他提供癌症诊疗的医院。
  • PPS豁免癌症中心与NCI癌症中心附属医院在18项调整后术后结局中的15项相似,包括死亡率、再入院和手术部位感染。
  • 与PPS豁免癌症中心相比,NCI癌症中心患者术后脓毒症发生率3.1% vs 1.7%(P=.002),急性肾衰竭6.2% vs 3.9%(P=.01),尿路感染6.4% vs 4.0%(P=.002)。
  • 与其他提供癌症诊疗的医院相比,PPS豁免癌症中心状态与18项结局中的7项改善相关,包括死亡率、脓毒症、急性肾衰竭、呼吸衰竭和抢救失败。
  • PPS豁免癌症中心的《美国新闻》声誉评分均值(SD)为17.5(24.0),NCI癌症中心为2.6(4.8),P<.001。

证据类型、等级与局限

  • 证据类型为回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Congress has exempted 11 specialized cancer centers in the United States from the Prospective Payment System (PPS). These centers are also exempt from reporting many of the process-of-care and outcome measures to the Centers for Medicare & Medicaid Services that are required for hospitals in the PPS. It is not known how hospitals affiliated with PPS-exempt cancer centers differ from other hospitals affiliated with National Cancer Institute cancer centers (NCI-CCs) or other US hospitals that provide cancer care.

OBJECTIVE: To examine differences between hospitals affiliated with PPS-exempt cancer centers, other hospitals affiliated with NCI-CCs, and other hospitals that provide cancer care on metrics that could be used in public reporting.

DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study compared hospital characteristics and cancer-related services using data from the American Hospital Association Annual Survey and US News Best Hospitals rankings. With a 100% sample of Medicare beneficiaries who underwent 1 of 9 cancer operations (brain tumor resection, colorectal resection, cystectomy, esophagectomy, gastrectomy, liver resection, lung resection, pancreatic resection, prostatectomy) from January 1, 2011, to May 31, 2015, we used hierarchical logistic regression methods to compare differences in 18 postoperative outcomes. Data analysis was conducted from February 2018 to August 2018.

MAIN OUTCOMES AND MEASURES: This study evaluated hospital characteristics, including cancer-specific services, patient comorbidity burden, and cancer surgery postoperative outcomes, from PPS-exempt cancer centers, NCI-affiliated cancer centers, and other US hospitals that provide cancer care.

RESULTS: Hospitals affiliated with PPS-exempt cancer centers (n = 15) and NCI-CCs (n = 54) were similar in hospital characteristics, basic cancer-related services, and patient comorbidity burden. Compared with NCI-CCs, PPS-exempt cancer centers had significantly higher US News reputation scores (mean [SD], 17.5 [24.0] vs 2.6 [4.8]; P < .001) but no differences in oncology patient volume, patient safety ratings, comorbidity burden, nurse staffing, US News total cancer scores, or US News survival scores. Hospitals affiliated with PPS-exempt cancer centers and NCI-CCs had similar adjusted postoperative outcomes for 15 of 18 measures, including mortality, readmission, and surgical site infections. Compared with hospitals affiliated with PPS-exempt cancer centers, patients treated at NCI-CCs were more likely to have postoperative sepsis (3.1% vs 1.7%; P = .002), acute renal failure (6.2% vs 3.9%; P = .01), and urinary tract infection (6.4% vs 4.0%; P = .002). Compared with the other hospitals that provide cancer care (n = 3578), PPS-exempt cancer center status was associated with improved outcomes for 7 of 18 measures, including mortality, sepsis, acute renal failure, pulmonary failure, and failure to rescue.

CONCLUSIONS AND RELEVANCE: Hospitals affiliated with PPS-exempt cancer centers and NCI-CCs had generally similar hospital characteristics, patient comorbidity burden, and cancer surgery outcomes. These findings raise questions about why some cancer centers are designated as PPS-exempt and why most hospitals are not required to publicly report cancer-specific quality metrics.

来源:JAMA Intern Med,查看原文。版权归原作者所有。

参考来源

  1. Merkow RP, Yang AD, Pavey E, et al. Comparison of Hospitals Affiliated With PPS-Exempt Cancer Centers, Other Hospitals Affiliated With NCI-Designated Cancer Centers, and Other Hospitals That Provide Cancer Care. JAMA Intern Med. 2019. PMID: 31206142. doi:10.1001/jamainternmed.2019.0914

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。